|Bid||111.9500 x 3400|
|Ask||111.9900 x 500|
|Day's Range||111.8575 - 112.2900|
|52 Week Range||91.3900 - 112.4200|
|PE Ratio (TTM)||-22.71|
|Expense Ratio (net)||0.25%|
After success in the company's phase 1/2 trial with BMN 270, an investigational gene therapy for hemophilia A, BioMarin Pharmaceuticals (BMRN) is expected to start phase 3 trials.
With the Edwards Intuity Elite valve system, Edwards Lifesciences aims to offer a minimally invasive therapy to complex aortic stenosis patients.
Of the 18 analysts tracking Southwest Airlines (LUV), six (33.3%) have rated the stock a "strong buy," and another six (33.3%) have recommended a "buy."